Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06771518

Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab

Led by Regina Elena Cancer Institute · Updated on 2025-01-13

37

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Investigate the role of consolidative radiotherapy treatment at the thoraco-mediastinal level in the patient suffering from lung microcytoma - extensive disease and treated with chemo-immunotherapy with atezolizumab, in association with maintenance therapy with atezolizumab.

CONDITIONS

Official Title

Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histological diagnosis of lung microcytoma
  • Age 18 years or older
  • Performance status according to ECOG 0-2
  • Extensive disease at the time of first line oncological treatment
  • Initial staging and restaging after chemo-immunotherapy with CT, CT-PET FDG, and brain MRI
  • At least partial response after chemo-immunotherapy according to the Impower 133 scheme
  • Haematological and respiratory toxicity less than or equal to grade 1, other toxicities less than or equal to grade 2 at the time of radiotherapy
  • Pulmonary function tests compatible with irradiation: FEV ≥1.2 l or >40%, DLCO ≥50%
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Previous radiotherapy treatment at the thoraco-mediastinal level
  • Disease progression after chemo-immunotherapy treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

"Regina Elena" National Cancer Institute

Rome, Italy, 00144

Actively Recruiting

Loading map...

Research Team

F

Francesco Dionisi, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab | DecenTrialz